BIOCERES CROP SOLUTIONS ($BIOX) is expected to release its quarterly earnings data on Thursday, November 13th before market open, per Finnhub. Analysts are expecting revenue of $92,029,500 and earnings of -$0.07 per share.
You can see Quiver Quantitative's $BIOX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIOCERES CROP SOLUTIONS Hedge Fund Activity
We have seen 11 institutional investors add shares of BIOCERES CROP SOLUTIONS stock to their portfolio, and 20 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BALLAST ASSET MANAGEMENT, LP added 306,624 shares (+69.9%) to their portfolio in Q3 2025, for an estimated $432,339
- ALLIANZ ASSET MANAGEMENT GMBH removed 213,488 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $301,018
- MAVEN SECURITIES LTD removed 85,673 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $382,958
- CITADEL ADVISORS LLC added 59,233 shares (+106.4%) to their portfolio in Q2 2025, for an estimated $264,771
- JANE STREET GROUP, LLC added 45,193 shares (+inf%) to their portfolio in Q2 2025, for an estimated $202,012
- ARDSLEY ADVISORY PARTNERS LP added 45,000 shares (+4.7%) to their portfolio in Q2 2025, for an estimated $201,150
- UBS GROUP AG removed 43,628 shares (-47.3%) from their portfolio in Q2 2025, for an estimated $195,017
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BIOCERES CROP SOLUTIONS Analyst Ratings
Wall Street analysts have issued reports on $BIOX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Lake Street issued a "Buy" rating on 09/10/2025
To track analyst ratings and price targets for BIOCERES CROP SOLUTIONS, check out Quiver Quantitative's $BIOX forecast page.
BIOCERES CROP SOLUTIONS Price Targets
Multiple analysts have issued price targets for $BIOX recently. We have seen 3 analysts offer price targets for $BIOX in the last 6 months, with a median target of $5.0.
Here are some recent targets:
- Ben Klieve from Lake Street set a target price of $5.0 on 09/10/2025
- Austin Moeller from Canaccord Genuity set a target price of $2.5 on 09/10/2025
- Kristen Owen from Oppenheimer set a target price of $6.0 on 07/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
